Neurology News

In adults aged 35 years or younger, women were 44% more likely to have an ischemic stroke compared with men, according to a systematic review.

Commercial-stage bioelectronic medicine company electroCore Inc. announced its noninvasive vagus nerve stimulation intervention for migraine prevention reduced the number of monthly headache days.

The FDA has granted final approval to Zydus for Sabril, an anticonvulsant used to treat children aged 1 month to 2 years with infantile spasms.

In this episode, Joel M. Gelfand, MD, MSCE, is joined by Leonard H. Calabrese, DO, and Amesh Adalja, MD, FIDSA, as they discuss quarantine and isolation guidelines, emerging therapies to treat COVID-19, and the anticipated future of the COVID-19 pandemic.

The results of a new survey suggest that many physicians do not completely understand what the Americans with Disabilities Act means for them.

Surgical treatment at approximately 12.5 hours after aneurysmal subarachnoid hemorrhage correlated with improved outcomes, according to results of a cohort study published in JAMA Network Open.

Quviviq 25 mg and 50 mg enhanced sleep among patients with insomnia disorder, according to results of two randomized, double-blind, placebo-controlled, phase 3 trials published in The Lancet Neurology.

The FDA has granted breakthrough device designation to Diadem U.S. Inc. for AlzoSure Predict, its blood-based test for early prediction of Alzheimer’s disease.

Bereavement-related stress, particularly from the death of a child, may slightly increase risk for stroke, according to a bi-national, population-based cohort study published in Neurology.

Although vaccines reduce the overall risk for COVID-19 regardless of immune status, patients with immune dysfunction are at a “substantial risk” for breakthrough infection versus those without, according to data.